¼¼°èÀÇ Ã´Ãß ¾Ð¹Ú °ñÀý ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м®(2025-2031³â) :MedCore
Vertebral Compression Fracture Market Size, Share, & Trends Analysis | Global | 2025-2031 | MedCore | Includes: Vertebroplasty and Percutaneous Vertebral Augmentation Markets
»óǰÄÚµå
:
1717652
¸®¼Ä¡»ç
:
iData Research Inc.
¹ßÇàÀÏ
:
2025³â 04¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 72 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¼¼°è ôÃß ¾Ð¹Ú °ñÀý(VCF) ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 11¾ï ´Þ·¯¸¦ ³Ñ¾ú½À´Ï´Ù.
ÀÌ º¸°í¼´Â µÎ °¡Áö ÁÖ¿ä ºÎ¹®À» ´Ù·ì´Ï´Ù.
- °æÇÇÀû ôÃßÁõ´ë¼ú(PVA)
- ôÃß ¼ºÇü¼ú
Æ÷ÇÔµÈ ½ÃÀå µ¥ÀÌÅÍ
- ÆÇ¸Å ´ë¼ö
- Æò±Õ ÆÇ¸Å °¡°Ý(ASP)
- ½ÃÀå ±Ô¸ð ¹× ¼ºÀå µ¿Çâ
- ¼ö¼ú °Ç¼ö
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ
- 2031³â±îÁö ½ÃÀå ¿¹Ãø
- 2024³â±îÁö ½ÇÀû µ¥ÀÌÅÍ
- ÇÕº´°ú Àμö
- ±â¾÷ ÇÁ·ÎÆÄÀÏ ¹× Á¦Ç° Æ÷Æ®Æú¸®¿À
- ÁÖ¿ä °æÀï ºÐ¼®
¼¼°è VCF ½ÃÀå µ¿Çâ
- ¼ºÀå·üÀº Å©°Ô ´Ù¸£Áö¸¸ Àü Áö¿ª¿¡¼ ½ÃÀå ¼ºÀåÀÌ ¿¹ÃøµË´Ï´Ù.
- ¼ºÀå·ü¿¡¼´Â Áßµ¿ÀÌ ¸®µåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
- ´ÙÀ½À¸·Î ¾ÆÇÁ¸®Ä«, ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ µÇ°í ÀÖ½À´Ï´Ù.
- ºÏ¹Ì´Â ½ÃÀåÀÇ ¼º¼÷µµ¸¦ ¹Ý¿µÇÏ¿© °¡Àå ³·Àº ¼ºÀå·ü ¿¹ÃøÀÌ µÇ°í ÀÖ½À´Ï´Ù.
- ¼À¯·´µµ ¸¶Âù°¡Áö·Î ¼º¼÷Çϰí ÀÖ½À´Ï´Ù¸¸, ÀÎÇÁ¶ó°¡ È®½ÇÈ÷ Çϰí Àֱ⠶§¹®¿¡ ¼¼°è Á¦3À§¿¡ ·©Å©µÇ°í ÀÖ½À´Ï´Ù.
- ¼º¼÷µµ°¡ ³·Àº Áö¿ª ½ÃÀå ¼ºÀåÀº Áø´Ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, ¼ö¼ú ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¾×¼¼½º °³¼±¿¡ ÀÇÇØ ÃÊ·¡µË´Ï´Ù.
¼¼°è VCF ½ÃÀå Á¡À¯À²
- Medtronic
- 2024³â ½ÃÀå ÀüüÀÇ 50% °¡±îÀ̸¦ Â÷ÁöÇÏ´Â ¼¼°è ½ÃÀåÀÇ ¸®´õ
- ºÏ¹Ì¿Í ¼À¯·´¿¡¼ °ÇÑ ¿ìÀ§¼º
- KyphX(R) ½Ã½ºÅÛÀ» Á¦°øÇÏ°í ¿©·¯ ±¹°¡¿¡¼ PVA ºÎ¹®À» ¼±µµ
- Stryker
- VCF ½ÃÀå¿¡¼ ¼¼°è 2À§
- Á¦Ç°Àº ´ÙÀ½°ú °°½À´Ï´Ù :
- AutoPlex(TM) ½Ã¸àÆ® ¹Í¼ ¹× °ø±Þ ½Ã½ºÅÛ
- VertaPlex(TM), VertaPlex HV(TM), SpinePlex(R) »À ½Ã¸àÆ®
- iVAS(TM) PVA ½Ã½ºÅÛ
- AVAflex dz¼± ½Ã½ºÅÛ ¹× AVAmax(R)
- °æÀï»ç¿¡ ºñÇØ ºñ¿ë È¿À²ÀûÀÎ ´ëüǰ°ú »ç¿ë ¿ëÀ̼ºÀ¸·Î ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù.
- DePuy Synthes
- 2024³â ½ÃÁ¡¿¡¼ ¼¼°è Á¦3À§ÀÇ °æÀï ±â¾÷
- Á¦Ç° Æ÷Æ®Æú¸®¿À´Â ´ÙÀ½°ú °°½À´Ï´Ù:
- CONFIDENCE(TM) ôÃß ½Ã¸àÆ® ½Ã½ºÅÛ
- VERTECEM(TM) V »À ½Ã¸àÆ®
- ºÏ¹Ì¿Í ¼À¯·´¿¡¼ °ÇÑ Á¸Àç°¨
- ÃßüÁõ´ë¼ú¿¡¼ÀÇ Àü´Þ Á¦¾î¿Í ¾ÈÁ¤¼º¿¡ ÁÖ·Â
½ÃÀå ¼¼ºÐÈ ¿ä¾à
- ôÃß ¼ºÇü¼ú
- °æÇÇÀû ôÃßÁõ´ë¼ú(PVA)
Á¶»ç ¹üÀ§ ¿ä¾à
- ´ë»ó Áö¿ª
- ºÏ¹Ì: ij³ª´Ù, ¹Ì±¹
- ¶óƾ¾Æ¸Þ¸®Ä« : ¾Æ¸£ÇîÆ¼³ª, º¼¸®ºñ¾Æ, ºê¶óÁú, Ä¥·¹, ÄÝ·Òºñ¾Æ, ÄÚ½ºÅ¸¸®Ä«, µµ¹Ì´ÏÄ« °øÈ±¹, ¿¡Äâµµ¸£, °úÅ׸»¶ó, ¸ß½ÃÄÚ, ÆÄ³ª¸¶, ÆÄ¶ó°úÀÌ, Æä·ç, Ǫ¿¡¸£Å丮ÄÚ, ¿ì·ç°úÀÌ, º£³×¼ö¿¤¶ó
- ¼À¯·´ : ¿À½ºÆ®¸®¾Æ, º£³×·è½º, ÇÁ¶û½º, µ¶ÀÏ, ÀÌÅ»¸®¾Æ, Æ÷¸£Åõ°¥, ½ºÄµð³ªºñ¾Æ, ½ºÆäÀÎ, ½ºÀ§½º, ¿µ±¹
- ÁßÀ¯·´ ¹× µ¿À¯·´ : ¾ÆÁ¦¸£¹ÙÀÌÀÜ, ¹ßÆ® »ï±¹, º§·Î·ç½Ã, ºÒ°¡¸®¾Æ, Å©·Î¾ÆÆ¼¾Æ, üÄÚ °øÈ±¹, Á¶Áö¾Æ, ±×¸®½º, Çë°¡¸®, Ä«ÀÚÈ彺ź, Æú¶õµå, ·ç¸¶´Ï¾Æ, ·¯½Ã¾Æ, ¼¼¸£ºñ¾Æ, ½½·Î¹ÙŰ¾Æ, ½½·Îº£´Ï¾Æ, Æ¢¸£Å°¿¹, ¿ìÅ©¶óÀ̳ª
- Áßµ¿ : ¹Ù·¹ÀÎ, À̶õ, À̽º¶ó¿¤, Äí¿þÀÌÆ®, ¿À¸¸, īŸ¸£, »ç¿ìµð¾Æ¶óºñ¾Æ, ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
- ¾Æ½Ã¾ÆÅÂÆò¾ç: È£ÁÖ, įº¸µð¾Æ, Áß±¹, È«Äá, Àεµ, Àεµ³×½Ã¾Æ, ÀϺ», ۸£±â½º½ºÅº, ¸¶Ä«¿À, ¸»·¹À̽þÆ, ¸ù°ñ, ¹Ì¾á¸¶, ´ºÁú·£µå, ÆÄŰ½ºÅº, Çʸ®ÇÉ, ½Ì°¡Æ÷¸£, Çѱ¹, ½º¸®¶ûÄ«, ´ë¸¸, ű¹, ¿ìÁŰ½ºÅº, º£Æ®³²
- ¾ÆÇÁ¸®Ä«: ¾ËÁ¦¸®, ÀÌÁýÆ®, ¿¡Æ¼¿ÀÇǾÆ, °¡³ª, ÄɳÄ, ¸®ºñ¾Æ, ¸ð·ÎÄÚ, ³ªÀÌÁö¸®¾Æ, ³²¾ÆÇÁ¸®Ä«, ¼ö´Ü, ¿ì°£´Ù
- ±âÁØ¿¬µµ : 2024³â
- ¿¹Ãø ±â°£ : 2025-2031³â
- °ú°Å µ¥ÀÌÅÍ : 2021-2023³â
Á¤·® µ¥ÀÌÅÍ
- ¼ö¼ú °Ç¼ö
- ½ÃÀå ±Ô¸ð
- ½ÃÀå Á¡À¯À²
- ½ÃÀå ¿¹Ãø
- ½ÃÀå ¼ºÀå·ü
- ÆÇ¸Å ´ë¼ö
- Æò±Õ ÆÇ¸Å °¡°Ý
ÁúÀû µ¥ÀÌÅÍ
- ½ÃÀå ¼ºÀå µ¿Çâ
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
- °æÀï ºÐ¼®
- ÇÕº´Àμö
- ±â¾÷ ÇÁ·ÎÆÄÀÏ
- Á¦Ç° Æ÷Æ®Æú¸®¿À
- FDA ¸®ÄÝ
- ÆÄ±«Àû ±â¼ú
µ¥ÀÌÅÍ ¼Ò½º
- ¾÷°è ¸®´õ¿ÍÀÇ 1Â÷ ÀÎÅͺä
- Á¤ºÎ ÀÇ»ç µ¥ÀÌÅÍ
- ±ÔÁ¦ µ¥ÀÌÅÍ
- º´¿ø µ¥ÀÌÅÍ
- ¼öÃâÀÔ µ¥ÀÌÅÍ
- »ç³» µ¥ÀÌÅͺ£À̽º
ÀÌ º¸°í¼´Â ¼¼°èÀÇ Ã´Ãß ¾Ð¹Ú °ñÀý ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä¿Í ÇÔ²² ½ÃÀå ºÐ¼®°ú ¿¹Ãø, ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ, °æÀï ±¸µµ µîÀ» Á¦°øÇÕ´Ï´Ù.
¸ñÂ÷
ôÃß ¾Ð¹Ú °ñÀý ½ÃÀå
ÁÖ¿ä ¿ä¾à
- °³¿ä : ¼¼°èÀÇ Ã´Ãß ¾Ð¹Ú °ñÀý ½ÃÀå
- °æÀï ºÐ¼®
- ½ÃÀå ¼¼ºÐÈ
- ´ë»ó Áö¿ª
¼Ò°³
- °æÇÇÀû ôÃß ¼ºÇü¼ú
- PVA(Ãßü ¼ºÇü¼ú Æ÷ÇÔ)
¼ö±â °Ç¼ö
- ÀüôÃ߾йڰñÀý ¼ö¼ú
- ôÃß ¼ºÇü¼ú
- °æÇÇÀû ôÃßÁõ´ë¼ú
½ÃÀå °³¿ä
½ÃÀå ºÐ¼® ¹× ¿¹Ãø
- ÀüôÃ߾йڰñÀý½ÃÀå
- ôÃß¼ºÇü¼ú ½ÃÀå
- °æÇÇÀû ôÃßÁõ´ë¼ú ½ÃÀå
ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ
°æÀï ½ÃÀå Á¡À¯À² ºÐ¼®
JHS
¿µ¹® ¸ñÂ÷
The global VCF market was valued at over $1.1 billion in 2024.
It is projected to grow at a CAGR of 5.2%, reaching over $1.6 billion by 2031.
The report covers two primary segments:
- Percutaneous Vertebral Augmentation (PVA)
- Vertebroplasty
Market Data Included
- Unit Sales
- Average Selling Prices (ASPs)
- Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts to 2031
- Historical Data to 2024
- Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitor Analysis
Global VCF Market Trends
- All regions are projected to experience market growth, though the rate of growth varies significantly:
- Middle East is expected to lead in growth rate.
- Followed by Africa and Asia-Pacific.
- North America has the lowest growth forecast, reflecting market maturity.
- Western Europe is similarly mature but ranks third globally due to its strong infrastructure.
- Market growth in less mature regions is driven by increased diagnosis, rising elderly populations, and better access to surgical solutions.
Global VCF Market Share Insights
- 1 Medtronic
- Global market leader in 2024, holding close to 50% of the total market value.
- Strong dominance in North America and Western Europe.
- Offers the KyphX(R) system and leads the PVA segment in multiple countries.
- 2 Stryker
- Ranked second globally in the VCF market.
- Products include:
- AutoPlex(TM) cement mixer and delivery system
- VertaPlex(TM), VertaPlex HV(TM), and SpinePlex(R) bone cements
- iVAS(TM) PVA system
- AVAflex Balloon System and AVAmax(R)
- Known for cost-effective alternatives and ease of use compared to competitors.
- 3 DePuy Synthes
- Third-largest competitor globally in 2024.
- Product portfolio includes:
- CONFIDENCE(TM) Spinal Cement System
- VERTECEM(TM) V+ bone cement
- Strong presence in North America and Western Europe.
- Focused on controlled delivery and stability in vertebral augmentation procedures.
Market Segmentation Summary
- Vertebroplasty
- Percutaneous Vertebral Augmentation (PVA)
Research Scope Summary
- Regions Covered
- North America: Canada, United States
- Latin America: Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
- Western Europe: Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom
- Central & Eastern Europe: Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine
- Middle East: Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates
- Asia-Pacific: Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam
- Africa: Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda
- Base Year: 2024
- Forecast Period: 2025-2031
- Historical Data: 2021-2023
Quantitative Data
- Procedure Numbers
- Market Size
- Market Shares
- Market Forecasts
- Market Growth Rates
- Units Sold
- Average Selling Prices
Qualitative Data
- Market Growth Trends
- Market Limiters
- Competitive Analysis
- Mergers & Acquisitions
- Company Profiles
- Product Portfolios
- FDA Recalls
- Disruptive Technologies
Data Sources
- Primary Interviews with Industry Leaders
- Government Physician Data
- Regulatory Data
- Hospital Private Data
- Import & Export Data
- iData Research Internal Database
TABLE OF CONTENT
Vertebral Compression Fracture Market
- 9.1 Executive Summary
- 9.1.1 Global Vertebral Compression Fracture Market Overview
- 9.1.2 Competitive Analysis
- 9.1.3 Procedure Segmentation
- 9.1.4 Market Segmentation
- 9.1.5 Regions Included
- 9.2 Introduction
- 9.2.1 Percutaneous Vertebroplasty
- 9.2.2 PVA Including Kyphoplasty
- 9.3 Procedure Numbers
- 9.3.1 Total Vertebral Compression Fracture Procedures
- 9.3.2 Vertebroplasty Procedures
- 9.3.3 Percutaneous Vertebral Augmentation Procedures
- 9.4 Market Overview
- 9.4.1 By Segment
- 9.4.2 By Region
- 9.5 Market Analysis and Forecast
- 9.5.1 Total Vertebral Compression Fracture Market
- 9.5.2 Vertebroplasty Market
- 9.5.3 Percutaneous Vertebral Augmentation Market
- 9.6 Drivers and Limiters
- 9.6.1 Market Drivers
- 9.6.2 Market Limiters
- 9.7 Competitive Market Share Analysis
°ü·ÃÀÚ·á